Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.3 Certificate of Amendment to the Certificate of Incorporation of Allarity Therapeutics, Inc
- 4.1 Specimen Common Stock Certificate of Allarity Therapeutics, Inc
- 10.11 First Amendment to the Exclusive License Agreement Between Eisai and Allarity Therapeutics A/s Dated December 20, 2020
- 10.12 Second Amendment to Exclusive License Agreement Between Oncology Venture, Aps and Eisai, Inc. Dated As of August 3, 2021
- 23.1 Consent of Pricewaterhousecoopers
- Download Excel data file
- View Excel data file
ALLR similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of Allarity Therapeutics, Inc., of our report dated August 20, 2021 relating to the financial statements of Allarity Therapeutics A/S, which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Copenhagen, Denmark
September 13, 2021